Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126056451 | 12605645 | 1 | I | 20160719 | 20160729 | 20160729 | EXP | GB-TEVA-678969ACC | TEVA | 0.00 | M | Y | 0.00000 | 20160729 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126056451 | 12605645 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 76017 | ||||||||||
| 126056451 | 12605645 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | U | 76017 | |||||||||||
| 126056451 | 12605645 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | U | 76017 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126056451 | 12605645 | 1 | Neuralgia |
| 126056451 | 12605645 | 2 | Paraesthesia |
| 126056451 | 12605645 | 3 | Eating disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126056451 | 12605645 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126056451 | 12605645 | Adverse event | |
| 126056451 | 12605645 | General physical health deterioration | |
| 126056451 | 12605645 | Insomnia | |
| 126056451 | 12605645 | Lung cancer metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |